Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery

• Sponsor: Zhujiang Hospital (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT03074708
• Collaborator: (none)
• Enrollment: 200
• Location: 1
• Arm: 1
• Anticipated Duration (Months): 21
• Patients Per Site Per Month: 9.5

Study Details

Study Description

Brief Summary

Background:The aim of the study is to value the application of three-dimensional visualization and three-dimensional printing in the hepatobiliary and pancreatic surgery.Method：From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.

Condition or Disease	Intervention/Treatment	Phase
Liver Diseases; Pancreatic Diseases; Biliary Tract Diseases	Other: 3D visualization and 3D printing	N/A

Detailed Description

From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 200 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Diagnostic
• Official Title: Zhujiang Hospital of the Southern Medical University
• Anticipated Study Start Date: Mar 1, 2017
• Anticipated Primary Completion Date: Dec 1, 2018
• Anticipated Study Completion Date: Dec 1, 2018

Arms and Interventions

Arm

Intervention/Treatment

Other: 3D visualization and 3D printing From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.

Other: 3D visualization and 3D printing; From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.

Outcome Measures

Primary Outcome Measures

1. operative time [1 year]

   operative time

Secondary Outcome Measures

1. intraoperative blood loss [1 year]

   intraoperative blood loss

2. postoperative complications after surgery [1 year]

   postoperative complications after surgery

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• the hepatobiliary and pancreatic diseases

Exclusion Criteria:

• none of the hepatobiliary and pancreatic diseases

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Zhujiang Hospital of The Southern Medical University	Guangzhou	Guangdong	China	510282

Sponsors and Collaborators

• Zhujiang Hospital

Investigators

• Study Chair: Chihua Fang, MD, Zhujiang Hospital of The Southern Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Chihua Fang, Dr, Zhujiang Hospital
• ClinicalTrials.gov Identifier: NCT03074708
• Other Study ID Numbers: 001
• First Posted: Mar 9, 2017
• Last Update Posted: Mar 9, 2017
• Last Verified: Mar 1, 2017

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Chihua Fang, Dr, Zhujiang Hospital: Three-Dimensional Image; Three Dimensional Printing
• Additional relevant MeSH terms: Liver Diseases; Pancreatic Diseases; Biliary Tract Diseases

Study Results

No Results Posted as of Mar 9, 2017